Secondary Histiocytic Sarcoma in a Pre-B-Acute Lymphoblastic Leukemia

Author:

Ramakrishnan Sharanya1ORCID,Radhakrishnan Vivek1ORCID,Dhabe Aaishwarya2,Parihar Mayur3,Zameer Lateef4,Arora Neeraj5ORCID,Nair Reena6ORCID

Affiliation:

1. Department of Clinical Haematology and Cellular Therapies, Tata Medical Center, Kolkata, West Bengal, India

2. Department of Cytogenetics, Tata Medical Center, Kolkata, West Bengal, India

3. Department of Cytogenetics & Laboratory Haematology, Tata Medical Center, Kolkata, West Bengal, India

4. Department of Pathology, Tata Medical Center, Kolkata, West Bengal, India

5. Unipath Speciality Laboratory, Ahmedabad, Gujarat, India

6. Head, Department of Clinical Hematology and Cellular therapies, Tata Medical Center, Kolkata, West Bengal, India

Abstract

AbstractHistiocytic sarcoma (HS) is a rare malignancy with grave prognosis. Adult acute lymphoblastic leukemia (ALL) patients developing HS as a secondary malignancy reported in the literature is even rarer. Through our case report, we aim to describe an adult pre-B-ALL patient who subsequently developed extensive HS while on maintenance therapy. We present the course of the disease, the management, and the resultant outcome. Active reporting of the course and management of secondary HS in adult ALL patients need to be emphasized to gain better insight into the presentation and the course of the disease, incidence as well as molecular pathology, especially given the relative silence of the literature in this regard.

Publisher

Georg Thieme Verlag KG

Reference17 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3